The Oxford Centre for Early Cancer Detection (OxCODE) brings together high calibre multi-disciplinary early cancer detection researchers from across > 40 departments, units and institutes in Oxford to collaborate and maximise research outputs in this area. Early detection is the future of cancer research and will transform cancer care to achieve enhanced cancer cure. OxCODE’s vision is to harness our existing strengths and expertise to generate a Quantitative Risk Score - the ‘Oxford QR code’ - an integrated multi-parameter readout to stratify an individual’s risk of developing malignant cancer. This will enable early detection with accompanying prognostic information for patient benefit.
Join our mailing list
OxCODE is open to students or employees of Oxford University or Oxford University Hospitals NHS Foundation Trust who have an interest in early cancer detection research. Email us if you wish to join the mailing list to hear about future events and funding opportunities.
News and Events
Ultrasensitive detection of p53 cancer biomarker
15 March 2024
First patient recruited to MILI trial
26 January 2024
Oxford Centre for Early Cancer Detection Symposium 2023 – a recap
14 December 2023